Abstract | BACKGROUND: This study aimed to compare the effects of sesame (SO), canola (CO), and sesame-canola (SCO: a blend) oils on glycaemic control markers and liver function enzymes in adults with type 2 diabetes. METHODS: In this randomized, triple-blind, three-way, cross-over clinical trial, participants replaced their usual oil with the intervention oils for 9 weeks. Serum fasting blood sugar, fasting serum insulin (FSI), insulin resistance (HOMA2-IR), beta-cell function (HOMA2-% B), insulin sensitivity (HOMA2-%S), quantitative insulin sensitivity check index (QUICKI), as well as serum liver function enzymes were measured at baseline and end of intervention periods. RESULTS: Ninety-two participants completed all treatment periods. After adjusting for confounders, all treatment oils resulted in significant improvements in FSI and HOMA2-%S (p < 0.05). SO and SCO led to favourable changes in HOMA2-IR and QUICKI (p < 0.05). Following CO and SCO, there was a significant decrease in HOMA2-%B (p < 0.05). The sex-stratified analysis revealed that FSI and HOMA2-IR were decreased after SO compared to CO in males (p = 0.024). Serum gamma-glutamyltransferase (GGT) was significantly lower following SO compared to CO in females (p = 0.02), however, the difference in change values was not significant (p = 0.058). CONCLUSIONS: SO consumption appears to improve glycaemic control markers in males and serum GGT in females compared with CO in patients with type 2 diabetes (registration code: IRCT2016091312571N6).
|
Authors | Hamidreza Raeisi-Dehkordi, Mojgan Amiri, Alireza Zimorovat, Fatemeh Moghtaderi, Sadegh Zarei, Scott C Forbes, Amin Salehi-Abargouei |
Journal | Diabetes/metabolism research and reviews
(Diabetes Metab Res Rev)
Vol. 37
Issue 5
Pg. e3399
(07 2021)
ISSN: 1520-7560 [Electronic] England |
PMID | 32860716
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 John Wiley & Sons Ltd. |
Chemical References |
|
Topics |
- Cross-Over Studies
- Diabetes Mellitus, Type 2
(drug therapy)
- Female
- Glycemic Control
- Humans
- Insulin Resistance
- Liver
- Male
- Rapeseed Oil
- Sesame Oil
- Sesamum
|